Security key
89422G107
Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX)
CUSIP: 89422G107
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 92,930,114
- Total 13F shares
- 85,573,515
- Share change
- +3,019,599
- Total reported value
- $769,316,791
- Put/Call ratio
- 197%
- Price per share
- $8.99
- Number of holders
- 162
- Value change
- +$27,493,568
- Number of buys
- 82
- Number of sells
- 86
Report period
Q4 2023
Institutions
162
Top holders
10
TVTX full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Travere Therapeutics, Inc. SEC filings
Travere Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89422G107
Recent filing periods:
Top shareholders of TVTX - Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
8.2%
|
7,633,205
|
$68,240,853 | — | 30 Sep 2023 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
8.1%
|
7,500,000
|
$67,050,000 | — | 30 Sep 2023 | |
| Deep Track Capital, LP |
13F
|
Company |
7.9%
|
7,370,000
|
$65,887,800 | — | 30 Sep 2023 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
5%
|
4,671,859
|
$41,766,000 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
5%
|
4,667,458
|
$41,727,074 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
4.7%
|
4,395,257
|
$39,293,598 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
3.6%
|
3,353,381
|
$29,979,226 | — | 30 Sep 2023 | |
| Venrock Adviser, LLC |
13F
|
Company |
2.8%
|
2,623,677
|
$23,455,672 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
2.4%
|
2,240,337
|
$20,028,613 | — | 30 Sep 2023 | |
| Woodline Partners LP |
13F
|
Company |
2.3%
|
2,150,565
|
$19,226,051 | — | 30 Sep 2023 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
2.3%
|
2,140,540
|
$19,136,428 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.1%
|
1,994,122
|
$17,827,000 | — | 30 Sep 2023 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.9%
|
1,807,742
|
$16,161,213 | — | 30 Sep 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.8%
|
1,671,770
|
$14,945,624 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.6%
|
1,512,087
|
$13,518,058 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
1,440,644
|
$12,880,945 | — | 30 Sep 2023 | |
| Avidity Partners Management LP |
13F
|
Company |
1.4%
|
1,323,000
|
$11,827,620 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.3%
|
1,215,226
|
$10,864,120 | — | 30 Sep 2023 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
1.1%
|
1,060,302
|
$9,479,097 | — | 30 Sep 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.1%
|
983,545
|
$8,792,893 | — | 30 Sep 2023 | |
| Kynam Capital Management, LP |
13F
|
Company |
1%
|
957,502
|
$8,560,068 | — | 30 Sep 2023 | |
| MANGROVE PARTNERS IM, LLC |
13F
|
Company |
1%
|
945,417
|
$8,452,028 | — | 30 Sep 2023 | |
| Finepoint Capital LP |
13F
|
Company |
0.96%
|
895,821
|
$8,008,640 | — | 30 Sep 2023 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.95%
|
884,770
|
$7,909,844 | — | 30 Sep 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.88%
|
813,252
|
$7,270,473 | — | 30 Sep 2023 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.82%
|
764,603
|
$6,835,551 | — | 30 Sep 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.76%
|
705,303
|
$6,305,408 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.74%
|
690,020
|
$6,168,779 | — | 30 Sep 2023 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.62%
|
577,494
|
$5,162,796 | — | 30 Sep 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.62%
|
576,900
|
$5,157,486 | — | 30 Sep 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.61%
|
565,919
|
$5,059,316 | — | 30 Sep 2023 | |
| MPM BioImpact LLC |
13F
|
Company |
0.59%
|
552,846
|
$4,942,443 | — | 30 Sep 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.58%
|
542,562
|
$4,850,505 | — | 30 Sep 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.56%
|
524,000
|
$4,684,560 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.52%
|
483,711
|
$4,324,377 | — | 30 Sep 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.45%
|
415,834
|
$3,717,557 | — | 30 Sep 2023 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.43%
|
400,000
|
$3,576,000 | — | 30 Sep 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.39%
|
361,993
|
$3,236,217 | — | 30 Sep 2023 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.36%
|
337,614
|
$3,018,000 | — | 30 Sep 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.36%
|
333,371
|
$2,980,337 | — | 30 Sep 2023 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.36%
|
332,853
|
$2,975,706 | — | 30 Sep 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.33%
|
308,456
|
$2,757,597 | — | 30 Sep 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.31%
|
290,833
|
$2,600,047 | — | 30 Sep 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.31%
|
288,654
|
$2,580,568 | — | 30 Sep 2023 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.29%
|
271,517
|
$2,427,362 | — | 30 Sep 2023 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.27%
|
254,051
|
$2,271,216 | — | 30 Sep 2023 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.27%
|
252,298
|
$2,255,544 | — | 30 Sep 2023 | |
| Tri Locum Partners LP |
13F
|
Company |
0.27%
|
251,702
|
$2,250,216 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.26%
|
245,978
|
$2,199,043 | — | 30 Sep 2023 | |
| TWINBEECH CAPITAL LP |
13F
|
Company |
0.25%
|
228,786
|
$2,045,347 | — | 30 Sep 2023 |
Institutional Holders of Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX) as of Q4 2023
As of 31 Dec 2023,
Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX) was held by
162 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
85,573,515 shares.
The largest 10 holders included
BlackRock Inc., ARMISTICE CAPITAL, LLC, Deep Track Capital, LP, VANGUARD GROUP INC, STATE STREET CORP, MACQUARIE GROUP LTD, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, Rock Springs Capital Management LP, and DEUTSCHE BANK AG\.
This page lists
162
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
166
Q4 2023 holders
162
Holder diff
-4
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.